BG-C0979
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BG-C0979, covering 2026-02-17 to 2026-02-17. Get the full timeline:
Most recent: Clinical Trial Update: A First-in-Human Study of BG-C0979 in Adults With Advanced Solid Tumors [Phase 1]